Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells
Long-term effects beyond 8-12 week cycles remain unknown due to the nature of available evidence
Bazinet A, Desikan SP, Li Z, Rodriguez-Sevilla JJ, Venugopal S, Urrutia S, Montalban-Bravo G, Sasaki K, Chien KS, Hammond D, Kanagal-Shamanna R, Ganan-Gomez I, Kadia TM, Borthakur G , DiNardo CD, Daver NG, Jabbour EJ, Ravandi F, Kantarjian H, Garcia-Manero G
Investigating Neuroprotective Potential of Berberine, Levetiracetam and Their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy
Bolanos JP, Herrero-Mendez A, Fernandez-Fernandez S, Almeida A